Subject of the thesis is evaluation one of the plants of the biggest subcontractor of automotive components. The main goal of the thesis is to determine the enterprise value of Robert Bosch spol. s.r.o for the company management who wants to manage this value in terms of maximum fulfillment of the basic objectives of company owners. The value of the company refers to January 1. 2013. Evaluation is based on publicly available sources, mainly on informations from the annual reports. This data was consulted with employees of the company. In the theoretical part of the thesis, the process of evaluation is explained and some of the steps are examined in detail. In the practical part, introducing with the company and the business environment is made. Within the evaluation, financial and strategical analysis is prepared. The eavulation is based on yielding methods, method of discounted free cash flow and discounted economic value added.

The theme of this final thesis is an evaluation of a Hyundai Motor Manufacturing Czech, s.r.o company. The goal of this thesis is to determine the value of the company based on discounted free cash flow and discounted economic value added methods using only publicly available sources while respecting "going concern principle". The date of valuation is 1. 12. 2013. This thesis consists of two parts. The first part focuses on the evaluation methodology. The second part focuses on the company, its market and surroundings. It contains strategy and financial analysis of the company needed for the evaluation process. The evaluation process itself is afterwards analyzed and explained thoroughly.

The master's thesis deals with the determination of estimated market value of the pharmaceutical company Novartis Ltd. based on publicly available information for the needs of the owner and management. The estimated value of company refers to December 31, 2011. For this purpose, first, it is necessary to do a development analysis of macroeconomic indicators in the Czech market and analysis of pharmaceutical industry. In addition, the subsidiary company of Swiss group, but necessary also parent company as its the most "business partner" are presented. It is followed by financial analysis of the subsidiary branch Novartis Ltd., prognosis of value drivers, financial plan. In the final part of thesis, on the basic of the financial plan and assumption of company's continued existence, the value of company is determined, using discount methods with free cash flow to the equity.